ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
63,595.64
4.63%
S&P 500
5,631.22
0.28%
Dow Jones
40,211.72
0.53%
US Dollar vs Yen
158.095
-0.14%
Brent Oil
84.34
-0.30%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Akers Biosciences Inc (AKER)

  7. Akers Biosciences Inc (AKER) ニュース

AKER

Akers Biosciences (AKER)

Akers Biosciences Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:AKER
日付受信時刻ニュースソース見出しコード企業名
2020/05/1502 : 01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AKERAkers Biosciences Inc
2020/05/1502 : 00GlobeNewswire Inc.Akers Biosciences Announces $4.8 Million Registered Direct Offering Priced At-the-Market under Nasdaq RulesNASDAQ:AKERAkers Biosciences Inc
2020/05/1422 : 33GlobeNewswire Inc.Akers Biosciences and Premas Biotech Announce Successful Completion of Vaccine Prototype & Obtained First Images of VLPNASDAQ:AKERAkers Biosciences Inc
2020/05/0603 : 16Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AKERAkers Biosciences Inc
2020/04/2100 : 48Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AKERAkers Biosciences Inc
2020/04/1805 : 16Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:AKERAkers Biosciences Inc
2020/04/1805 : 16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AKERAkers Biosciences Inc
2020/04/1503 : 29Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:AKERAkers Biosciences Inc
2020/04/1422 : 21Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AKERAkers Biosciences Inc
2020/04/0822 : 25GlobeNewswire Inc.Akers Biosciences and Premas Biotech Announce Successful Expression of Coronavirus AntigensNASDAQ:AKERAkers Biosciences Inc
2020/04/0822 : 17Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:AKERAkers Biosciences Inc
2020/04/0819 : 21Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AKERAkers Biosciences Inc
2020/04/0819 : 00Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:AKERAkers Biosciences Inc
2020/04/0806 : 11Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:AKERAkers Biosciences Inc
2020/04/0723 : 53GlobeNewswire Inc.Akers Biosciences Announces $4.6 Million Registered Direct Offering Priced At-the-Market under Nasdaq RulesNASDAQ:AKERAkers Biosciences Inc
2020/04/0723 : 06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AKERAkers Biosciences Inc
2020/04/0719 : 03Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:AKERAkers Biosciences Inc
2020/04/0622 : 25GlobeNewswire Inc.Akers Biosciences and Premas Biotech Announce Progress in its Vaccine Development for Covid-19NASDAQ:AKERAkers Biosciences Inc
2020/03/2519 : 01Edgar (US Regulatory)Annual Report (10-k)NASDAQ:AKERAkers Biosciences Inc
2020/03/2505 : 06GlobeNewswire Inc.Akers Biosciences Schedules Conference Call to Discuss Licensing Announcement with Premas Biotech for a Coronvirus Vaccine Ca...NASDAQ:AKERAkers Biosciences Inc
2020/03/2422 : 22Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AKERAkers Biosciences Inc
2020/03/2422 : 00GlobeNewswire Inc.Akers Biosciences Acquires Licenses to Coronavirus Vaccine Candidate from Premas BiotechNASDAQ:AKERAkers Biosciences Inc
2020/03/0404 : 56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AKERAkers Biosciences Inc
2020/02/2806 : 12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AKERAkers Biosciences Inc
2020/01/1807 : 00GlobeNewswire Inc.Akers Biosciences, Inc. Provides Notice of Proposed Settlement of Derivative LitigationNASDAQ:AKERAkers Biosciences Inc
2019/12/1123 : 30GlobeNewswire Inc.Akers BioSciences Regains Compliance with Nasdaq Listing StandardsNASDAQ:AKERAkers Biosciences Inc
2019/12/1001 : 40GlobeNewswire Inc.Akers BioSciences, Inc. Announces Closing of Approximately $8 Million Public OfferingNASDAQ:AKERAkers Biosciences Inc
2019/12/0623 : 30GlobeNewswire Inc.Akers Biosciences to Attend Hemp Industry Daily Forum in Las Vegas, NevadaNASDAQ:AKERAkers Biosciences Inc
2019/12/0523 : 25GlobeNewswire Inc.Akers BioSciences, Inc. Announces Pricing of Approximately $8 Million Public OfferingNASDAQ:AKERAkers Biosciences Inc
2019/12/0522 : 45GlobeNewswire Inc.Akers Biosciences Continues Strategic Review; Explores Leveraging its 30-years of Laboratory Operations to Enter into the Hem...NASDAQ:AKERAkers Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:AKER

最近閲覧した銘柄

USOTC
RHHBY
Roche (QX)
CCOM
SILVER
SILVER
COIN
ETHUSD
Ethereum
AMEX
XLV
Health Care Select Sector
NYSE
KO
Coca Cola
COIN
SOLUSD
Solana
USOTC
BASFY
BASF (QX)
NYSE
AXP
American Express
NYSE
DIS
Walt Disney
AMEX
XLE
Energy Select Sector SPDR
NASDAQ
AMZN
Amazon.com
NYSE
VZ
Verizon Communications
AMEX
SPY
SPDR S&P 500
NYSE
NKE
Nike
FX
USDEUR
US Dollar vs Euro
FX
USDJPY
US Dollar vs Yen
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有